Medicines and Healthcare Products Regulatory Agency
London, United Kingdom
Purpose
to manufacture Shigella Lipopolysaccharide antigens of sufficient quality and quantity to provide a global supply to support the development of a Shigella vaccine for children in low- and middle-income countries
Division
Global Health
Date
November 2025
Region Served
GLOBAL
Committed amount
$924,926
Grant topic
Enterics, Diagnostics, Genomics & Epidemiology
Duration (months)
35
Grantee location
London, United Kingdom
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.